Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Stomach”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03116555
What this trial is testing

Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA

Who this might be right for
Metastatic Gastric Adenocarcinoma
China Medical University, China 37
Large-scale testing (Phase 3)Study completedNCT00002615
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Who this might be right for
Gastric Cancer
Medical Research Council 500
Testing effectiveness (Phase 2)Looking for participantsNCT07311408
What this trial is testing

SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Jingdong Zhang 40
Large-scale testing (Phase 3)UnknownNCT02773524
What this trial is testing

Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

Who this might be right for
Gastro-Oesophageal Cancer
Australasian Gastro-Intestinal Trials Group 250
Early research (Phase 1)Ended earlyNCT04171141
What this trial is testing

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Who this might be right for
Gastrointestinal TumorsColorectal AdenocarcinomasGastric Adenocarcinomas+1 more
Pfizer 79
Not applicableLooking for participantsNCT05539105
What this trial is testing

A Prospective Observation Registry Study on the Alimentary Reconstruction After Radical Proximal Gastrectomy

Who this might be right for
Proximal Gastric AdenocarcinomaReconstruction
Shanghai Zhongshan Hospital 600
Large-scale testing (Phase 3)Study completedNCT02494583
What this trial is testing

Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Who this might be right for
Gastric Adenocarcinoma
Merck Sharp & Dohme LLC 763
Testing effectiveness (Phase 2)Study completedNCT03941873
What this trial is testing

Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer

Who this might be right for
Carcinoma, HepatocellularGastric/Gastroesophageal Junction Cancer
BeiGene 111
Early research (Phase 1)Not Yet RecruitingNCT05038098
What this trial is testing

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
M.D. Anderson Cancer Center 20
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Very early researchLooking for participantsNCT06824363
What this trial is testing

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Who this might be right for
Solid Tumor, AdultMalignant Solid TumorStomach Adenocarcinoma+1 more
University of California, Irvine 34
Testing effectiveness (Phase 2)Study completedNCT03662659
What this trial is testing

An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers

Who this might be right for
Gastric CancerCancer of the StomachEsophagogastric Junction
Bristol-Myers Squibb 274
Testing effectiveness (Phase 2)Ended earlyNCT07040059
What this trial is testing

A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
HER 2 Positive Gastric CancerGastroesophageal Junction Adenocarcinoma
Aurigene Discovery Technologies Limited 2
Testing effectiveness (Phase 2)Looking for participantsNCT06992362
What this trial is testing

Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach

Who this might be right for
Hepatoid Adenocarcinoma of Stomach
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)UnknownNCT00763646
What this trial is testing

Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Junction AdenocarcinomaGastroesophageal Junction Adenocarcinoma
McGill University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07727993
What this trial is testing

Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPropranololSOX Chemotherapy+1 more
Ting Liu 49
Early research (Phase 1)Looking for participantsNCT07594964
What this trial is testing

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Who this might be right for
Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)+1 more
Shenzhen Xinhe Biomedical 48
Testing effectiveness (Phase 2)Study completedNCT04276493
What this trial is testing

Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Cancer
BeiGene 71
Not applicableLooking for participantsNCT06995898
What this trial is testing

The Vanguard Study: Testing a New Way to Screen for Cancer

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+8 more
National Cancer Institute (NCI) 24,000
Early research (Phase 1)WithdrawnNCT02598687
What this trial is testing

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Maastricht Radiation Oncology
Next Page